Wednesday, 20 August 2025

Afro-Buff

SOUTH AFRICA: Aspen secures urgent relief in MYBUCOD vs LENBUCOD dispute

Hey herd, Afro-Buff here, fresh from the gym and flexing through another heavyweight IP bout delivered this week by the Pretoria High Court. This time it’s Aspen vs Adcock, and trust me, the legal bench press was heavy.

 

Aspen, armed with its registered MYBUCOD mark (class 5, pharmaceuticals), took on Adcock’s use of the lookalike LENBUCOD. Back in May 2025, the Court benched Adcock with an interdict stopping LENBUCOD sales, ordering up destruction of packaging, and awarding Aspen its costs.

 

But Adcock wasn’t ready to tap out. They filed an appeal, hoping to stall enforcement. Aspen countered with a section 18(3) Superior Courts Act application, basically asking the Court: “Don’t just give us the win, let us enforce it now, even while Adcock appeals.”

 

Justice Millar agreed, delivering some serious legal gains for Aspen:

 

Exceptional circumstances: If Aspen had to wait until a likely late 2026 appeal, its victory would become a “vacuous gesture.” Trade Mark rights aren’t just for show and meant to protect in real time.

Irreparable harm to Aspen: In just six months, Adcock had pumped R8.4m (around USD500k) worth of LENBUCOD product into the market. Left unchecked, that level of trading would decimate MYBUCOD’s commercial value.

No irreparable harm to Adcock: Adcock knew MYBUCOD was registered and disputed but carried on anyway. If they eventually win on appeal, Aspen has promised to pay damages to repair any harm caused, like a physio on a torn muscle. The court also found that market re-entry was quite possible for Adcock (in the event of a successful appeal).

 

The Court also shut down Adcock’s argument that MYBUCOD was too small to matter: registration alone gives substantive rights, whether or not the brand is a market champion.

 

Why it matters (Afro-Buff’s take)

 

This case is a reminder that:

 

1. Registered rights are muscle, not fluff. You don’t need market bulk to enforce them.

2. Section 18(3) works, like a fast track protein shake keeping your rights strong while opponents try to run down the clock with appeals.

 

For brand rights owners, the message is clear: when an infringer tries to out-lift you by flooding the market during appeal delays, the law gives you the tools to keep your rights flexed and functional. Another reason to protect those trade marks by registering them!

 

Order: Aspen’s May 2025 interdict stays in force. Adcock pays costs (including two counsel).

 

Full judgment: AspenPharmacare Holdings Group and Another v Adcock Ingram Healthcare (Pty) Ltd andOthers (Gauteng High Court, Pretoria, Case No. 017055/2025, 18 August 2025)

.

Afro-Buff

Afro-Buff

Subscribe via email (you'll be added to our Google Group)